{"id":651209,"date":"2013-04-08T08:40:25","date_gmt":"2013-04-08T12:40:25","guid":{"rendered":"https:\/\/www.pehub.com\/?p=195063"},"modified":"2013-04-08T08:40:25","modified_gmt":"2013-04-08T12:40:25","slug":"water-street-backs-ccbr-synarc","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/651209","title":{"rendered":"Water Street Backs CCBR-SYNARC"},"content":{"rendered":"

Water Street Healthcare Partners<\/strong> has put an undisclosed amount into outsourced clinical services company CCBR- SYNARC<\/strong>. The deal is the first from Water Street Healthcare Partners III, L.P., which it closed last year with $750 million.
\n
\nPRESS RELEASE<\/strong>
\nWater Street Healthcare Partners, a strategic private equity firm focused exclusively on the health care industry, announced today that it has invested in CCBR- SYNARC. Comprised of two businesses that specialize in outsourced clinical services, CCBR- SYNARC expands Water Street\u2019s global presence in the pharmaceutical services sector. It also marks the health care firm\u2019s first investment from its new fund, Water Street Healthcare Partners III, L.P., which it closed last year after receiving $750 million of investor commitments in less than eight weeks.
\nCCBR-SYNARC is a highly specialized provider of clinical services to the world\u2019s largest pharmaceutical and biotechnology companies. The company\u2019s SYNARC business, based in Newark, Calif., specializes in imaging services, consultation and analysis to track progress throughout a clinical trial\u2019s life cycle. Its CCBR business, headquartered in Copenhagen, Denmark, recruits patients from all over the world, and conducts and manages clinical trials in its dedicated clinical centers. Together, the businesses employ more than 500 doctors, nurses and technicians who are located in 29 research centers across Asia, Europe and The Americas. They currently focus their expertise in the musculoskeletal, cardiovascular and neurological therapies.
\n\u201cWater Street\u2019s team has consistently demonstrated to us a deep understanding of our businesses since it first approached us about potential ways to work together several years ago,\u201d said Dr. Claus Christiansen, founder and chairman, CCBR-SYNARC. \u201cWhen we reached a point in our development in which we were ready to expand our capabilities and services, we knew Water Street was our ideal partner. Its experience in the pharmaceutical sector, business development expertise and extensive industry relationships will provide our businesses with the intellectual capital and resources to achieve long-term growth and success.
\nThe outsourced clinical development market is projected to grow as much as 5 to 10 percent per year over the next five years. With new regulations and global protocols leading to more complex drug development processes, pharmaceutical companies are increasingly turning to specialized providers such as CCBR-SYNARC to support them with particular aspects of their clinical trials.
\n\ufffc\ufffc\u2014 more \u2014
\n2
\nCCBR\u2019s ability to recruit large patient populations from diverse markets and SYNARC\u2019s high quality imaging capabilities have fueled the company\u2019s growth since its founding in 1998.
\n\u201cRecruiting patients to participate in clinical trials can be a significant pain point for pharmaceutical companies and can cause costly delays in their drug development processes,\u201d said Al Heller, an operating partner with Water Street who has more than 30 years of pharmaceutical experience. \u201cCCBR-SYNARC stands out for its proven ability to both quickly recruit patients from targeted geographies and efficiently analyze images to support customers while increasing their clinical trial success rates.\u201d
\nCCBR-SYNARC expands Water Street\u2019s group of companies specializing in health care products and services to 12. The firm is also an investor in AAIPharma Services Corp., a provider of pharmaceutical product development services. It sold its oral health pharmaceutical company, OraPharma, to Valeant Pharmaceuticals International, Inc. last year. Since its founding in 2005, Water Street has completed 39 transactions to create and grow a diverse group of market-leading health care companies.<\/p>\n

\u201cWe are pleased to build Water Street\u2019s presence in the pharmaceutical sector with our investment in CCBR-SYNARC. The company is highly regarded as a partner that delivers results through its unique combination of scientific acumen, local market knowledge and proprietary technology,\u201d said Peter Strothman, partner, Water Street. \u201cWe look forward to working closely with Dr. Christiansen to strategically expand both businesses\u2019 unique capabilities.\u201d
\nWater Street has activated its newest fund, Fund III, with its investment in CCBR-SYNARC. The firm is seeking new opportunities to partner with corporations interested in divesting non-core health care businesses, and middle-market companies wanting to accelerate growth. Water Street targets investments ranging from $50 to $500 million in four health care sectors: distribution, medical products, health care services, and pharmaceutical products and services.<\/p>\n

About Water Street
\nWater Street is a strategic private equity firm focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world\u2019s leading health care companies on its investments including Gentiva, Johnson & Johnson, Medtronic and Orthofix. Water Street\u2019s team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago.<\/p>\n

The post Water Street Backs CCBR-SYNARC<\/a> appeared first on peHUB<\/a>.<\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Water Street Healthcare Partners has put an undisclosed amount into outsourced clinical services company CCBR- SYNARC. The deal is the first from Water Street Healthcare Partners III, L.P., which it closed last year with $750 million. PRESS RELEASE Water Street Healthcare Partners, a strategic private equity firm focused exclusively on the health care industry, announced […]<\/p>\n","protected":false},"author":7427,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-651209","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/651209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/7427"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=651209"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/651209\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=651209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=651209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=651209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}